Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 363-368

  Ding, Lin Can ^a   She, Lin ^a   Zheng, Da Li ^a   Huang, Qing Ling ^a   Wang, Jin Feng ^a   Zheng, Fei Fei ^a   Lu, You Guang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Notch 4; Oral cancer; RNA interference; Salivary adenoid cystic carcinoma

Indexed keywords

NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH4 RECEPTOR; SMALL INTERFERING RNA; NOTCH RECEPTOR; NOTCH4 PROTEIN, HUMAN; ONCOPROTEIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA; UPREGULATION; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; SALIVARY GLAND TUMOR; TUMOR CELL CULTURE;

CARCINOMA, ADENOID CYSTIC; CASE-CONTROL STUDIES; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; RECURRENCE; RNA, SMALL INTERFERING; SALIVARY GLAND NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77954373718     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000868     Document Type: Article

References (31)

1. Lima SS, Soares AF, Amorim RF and Freitas Rde A: Epidemiologic profile of salivary gland neoplasms: analysis of 245 cases. Rev Bras Otorinolaryngol 71: 335-340, 2005.
2. Sherigar JM, Finnegan J, McManus D, Lioe TF and Spence RA: Extra salivary adenoid cystic carcinoma; report of two cases. Ulster Med J 75: 223-225, 2006. (Pubitemid 44308995)
3. Umeda M, Nishimatsu N, Masago H, Ishida Y, Yokoo S, Fujioka M, Shibuya Y and Komori T: Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 473-478, 1999.
4. Lu YG, Zhou HY, Ding LC, Mei Y, Xiong RH, Deng SS and Yang HJ: Analysis of differential expression genes related to different metastasis potential of adenoid cystic carcinoma using restriction fragments differential display PCR. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 505-510, 2006.
5. Zhou CX and Gao Y: Aberrant expression of beta-catenin, Pin1 and cyclin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 16: 505-511, 2006.
6. Go MJ, Eastman DS and Artavanis-Tsakonas S: Cell proliferation control by Notch signaling in Drosophila development. Development 125: 2031-2040, 1998.
7. Shelly LL, Fuchs C and Miele L: Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem 73: 164-175, 1999.
8. Allenspach EJ, Aster JC and Pear WS: Notch signaling in cancer. Cancer Biol Ther 1: 466-476, 2002.
9. GP Dotto: Notch tumor suppressor function. Oncogene 27: 5115-5123, 2008.
10. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS: Distinct pattern of expression of differentiation and growthrelated genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224, 2000.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
12. Sporn MB: The war on cancer. Lancet 347: 1377-1381, 1996.
13. Chadwick N, Zeef L, Portillo V, Fennessy C, Warrander F, Hoyle S and Buckle AM: Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 8: 35, 2009.
14. Hu C, Diévart A, Lupien M, Calvo E, Tremblay G and Jolicoeur P: Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 168: 973-990, 2006.
15. Mysliwiec P and Boucher MJ: Targeting Notch signaling in pancreatic cancer patients, rationale for new therapy. Adv Med Sci 54: 1-7, 2009.
16. Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, Devgan V, Lieb J, Raffoul W, Hohl D, Neel V, Garlick J, Chiorino G and Dotto GP: Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 21: 562-577, 2007.
17. Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC and Albertson DG: Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242, 2005.
18. Cobellis L, Caprio F, Trabucco E, Mastrogiacomo A, Coppola G, Manente L, Colacurci N, De Falco M and De Luca A: The pattern of expression of Notch protein members in normal and pathological endometrium. J Anat 213: 464-472, 2008.
19. Grigorian A, Hurford R, Chao Y, Patrick C and Langford TD: Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir. BMC Neurosci 9: 27, 2008.
20. Delbosc S, Glorian M, Le Port AS, Béréziat G, Andréani M and Limon I: The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am J Pathol 172: 1430-1440, 2008.
21. Joo YH, Jung CK, Kim MS and Sun DI: Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer. Otolaryngol Head Neck Surg 140: 512-518, 2009.
22. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, Zhong W, Saleem M, Din M, Setaluri V and Mukhtar H: Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15: 452-459, 2009.
23. Zhang P, Yang Y, Zweidler-McKay PA and Hughes DP: Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 14: 2962-2969, 2008.
24. Reinders J, Rozemuller EH, van der Weide P, Oka A, Slootweg PJ, Inoko H and Tilanus MG: Genes in the HLA region indicative for head and neck squamous cell carcinoma. Mol Immunol 44: 848-855, 2007. (Pubitemid 44415008)
25. Soriano JV, Uyttendaele H, Kitajewski J and Montesano R: Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int J Cancer 86: 652-659, 2000. (Pubitemid 30249875)
26. Nam DH, Jeon HM, Kim S, Kim MH, Lee YJ, Lee MS, Kim H, Joo KM, Lee DS, Price JE, Bang SI and Park WY: Activation of notch signaling in a xenograft model of brain metastasis. Clin Cancer Res 14: 4059-4066, 2008.
27. Leong KG, Hu X, Li L, Noseda M, Larrivée B, Hull C, Hood L, Wong F and Karsan A: Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol Cell Biol 22: 2830-2841, 2002.
28. Sun S, Du R, Gao J, Ning X, Xie H, Lin X, Liu J and Fan D: Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 41: 335-341, 2009.
29. Gao J, Song Z, Chen Y, Xia L, Wang J, Fan R, Du R, Zhang F, Hong L, Song J, Zou X, Xu H, Zheng G, Liu J and Fan D: Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis 40: 114-121, 2008.
30. Hu K, Li SL, Gan YH, Wang CY and Yu GY: Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt. Oral Oncol 45: 156-163, 2009.
31. Greer RO Jr, Said S, Shroyer KR, Marileila VG and Weed SA: Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol 43: 735-741, 2007.